
JARID1B - Wikipedia
Jarid1B (also known as KDM5B or PLU1) is in the family of JHDM genes. These are responsible for demethylation of tri- and di-methylated lysines in the 4 position of histone 3 (H3K4me3 and …
KDM5B Gene - GeneCards | KDM5B Protein | KDM5B Antibody
Mar 30, 2025 · KDM5B (Lysine Demethylase 5B) is a Protein Coding gene. Diseases associated with KDM5B include Intellectual Developmental Disorder, Autosomal Recessive 65 and Autism …
KDM5B promotes immune evasion by recruiting SETDB1 to silence ... - Nature
Oct 20, 2021 · Here we show that, in mouse melanoma models, depletion of KDM5B—an H3K4 demethylase that is critical for melanoma maintenance and drug resistance 13, 14, 15 …
KDM5B is a master regulator of the H3K4-methylome in stem cells ...
The histone lysine demethylase, KDM5B, which catalyzes the demethylation of histone 3 lysine 4 (H3K4), is important for embryonic stem (ES) cell differentiation, and is a critical regulator of …
Lysine demethylase 5B (KDM5B): A potential anti-cancer drug target
Jan 1, 2019 · Lysine demethylase 5B (KDM5B) is a histone demethylase identified in 2007, which is responsible for erasing H3K4me2/3 activation marker. It participates in multiple repressive …
Histone demethylase KDM5B licenses macrophage-mediated …
Mar 13, 2023 · Here, we demonstrated that lysine-specific demethylase 5B (KDM5B), a classical transcriptional repressor in stem cell development and cancer, was required for the full …
Diverse Functions of KDM5 in Cancer: Transcriptional Repressor or ...
KDM5B induces the luminal transcriptional program by downregulating basal genes and upregulating luminal genes. KDM5B also contributes to therapeutic resistance by inducing …
10765 - Gene ResultKDM5B lysine demethylase 5B [ (human)]
Feb 8, 2025 · Histone demethylase KDM5 regulates cardiomyocyte maturation by promoting fatty acid oxidation, oxidative phosphorylation, and myofibrillar organization. KDM5B promotes …
H3K4 demethylase KDM5B regulates cancer cell identity and
Apr 19, 2022 · The H3K4 demethylase KDM5B is overexpressed in multiple cancer types, and elevated expression levels of KDM5B is associated with decreased survival. However, the …
Lysine demethylase 5B (KDM5B): A key regulator of cancer drug ...
In this review, we explain the biological properties of KDM5B, its function in the emergence and evolution of cancer treatment resistance, and our hopes for future drug resistance-busting …